Overview
PEPS ranks this pair inside the Top 300 market-cap universe. That means Injective and RUNE are liquid enough for an indexable comparison, with metrics refreshed on the hourly coin pipeline.
Quick winners
Full comparison
| Metric | INJ | RUNE |
|---|---|---|
| Price | $5.13 | $0.446000 |
| Market Cap | $490.41M | $150.57M |
| FDV | — | — |
| Volume 24h | $2.59M | $485,437.88 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 195.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | RUNE |
|---|---|---|
| 1H | — | — |
| 24H | +3.91% | +2.29% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | RUNE |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 59.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Indicator stacks for INJ/RUNE currently lean on separate regimes: neutral versus bearish. Treat MACD and RSI as context, not as standalone entry triggers.
Fundamentals
| Metric | INJ | RUNE |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
RUNE
Pros and cons
Pros of Injective
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
- Injective typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Composite PEPS readings for Injective can surface clearer module agreement during trend phases.
Cons of Injective
- Crowded positioning around INJ sometimes amplifies squeeze or flush risk.
- Indicator stacks on Injective may stay stretched longer than expected in strong trends.
- When dominance narratives fade, Injective can lag hotter rotation names.
Pros of RUNE
- PEPS tracking for RUNE still includes AI score and level context for monitoring.
- Active volume bursts on RUNE sometimes precede sharper tactical moves.
- RUNE can offer higher relative beta when market attention rotates toward its niche.
Cons of RUNE
- Higher volatility on RUNE cuts both ways and demands stricter risk limits.
- Relative underperformance versus Injective can persist through entire market regimes.
- Smaller book depth versus large caps can increase slippage for RUNE.
Which looks stronger right now?
Data currently points to a probabilistic edge for Injective on size and Injective on activity. Neither reading guarantees future returns.
AI summary
In about three hundred words of context: Injective (INJ) trades near $5.13 with a +3.91% day move, while RUNE (RUNE) is around $0.446000 (+2.29%). Volume leadership currently sits with Injective, and market-cap leadership with Injective. Technical trend labels read neutral vs bearish, with RSI near 49.29/49.02. Bottom line: use this page as a structured checklist, then open each coin page and related PEPS tools before acting. Nothing here is financial advice.
FAQ
Which is better, Injective or RUNE?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or RUNE?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and RUNE.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.